ABELZETA RECEIVES FDA RMAT AND FAST TRACK DESIGNATIONS FOR PRIZLON-CEL IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA

Reuters · 2d ago

Please log in to view news